- Home
- AGYS vs SLNO Comparison
AGYS vs SLNO Comparison
Compare AGYS & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGYS
- SLNO
- Stock Information
- Founded
- AGYS 1963
- SLNO 1999
- Country
- AGYS United States
- SLNO United States
- Employees
- AGYS N/A
- SLNO N/A
- Industry
- AGYS EDP Services
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AGYS Technology
- SLNO Health Care
- Exchange
- AGYS Nasdaq
- SLNO Nasdaq
- Market Cap
- AGYS 2.4B
- SLNO 2.2B
- IPO Year
- AGYS N/A
- SLNO 2014
- Fundamental
- Price
- AGYS $77.54
- SLNO $46.13
- Analyst Decision
- AGYS Strong Buy
- SLNO Strong Buy
- Analyst Count
- AGYS 5
- SLNO 5
- Target Price
- AGYS $138.00
- SLNO $71.20
- AVG Volume (30 Days)
- AGYS 417.0K
- SLNO 390.6K
- Earning Date
- AGYS 01-21-2025
- SLNO 03-05-2025
- Dividend Yield
- AGYS N/A
- SLNO N/A
- EPS Growth
- AGYS N/A
- SLNO N/A
- EPS
- AGYS 0.79
- SLNO N/A
- Revenue
- AGYS $263,572,999.00
- SLNO N/A
- Revenue This Year
- AGYS $17.25
- SLNO N/A
- Revenue Next Year
- AGYS $20.76
- SLNO N/A
- P/E Ratio
- AGYS $98.15
- SLNO N/A
- Revenue Growth
- AGYS 15.53
- SLNO N/A
- 52 Week Low
- AGYS $74.03
- SLNO $36.61
- 52 Week High
- AGYS $142.64
- SLNO $60.92
- Technical
- Relative Strength Index (RSI)
- AGYS 25.84
- SLNO 40.51
- Support Level
- AGYS $81.84
- SLNO $48.48
- Resistance Level
- AGYS $88.89
- SLNO $52.46
- Average True Range (ATR)
- AGYS 3.43
- SLNO 2.07
- MACD
- AGYS 0.65
- SLNO -0.47
- Stochastic Oscillator
- AGYS 0.00
- SLNO 0.94
About AGYS Agilysys Inc.
Agilysys Inc has been a leader in hospitality software, delivering innovative cloud-native SaaS and on-premise solutions for hotels, resorts and cruise lines, casinos, corporate food service management, restaurants, universities, stadiums, and healthcare. The Company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. Agilysys also is known for its world-class customer-centric service.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.